Skip to main content

AHG · Akso Health Group

Track AHG — free
$1.25 +0.03 (+2.46%)
Market Cap
$1.05B
Shares
856.70M
Volume · Oct 23 1875 Avg daily vol (3M) 107.52K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.30 Open$1.30 Day$1.25–1.30 52W close$0.69–2.50 Avg vol 30d209K Short int19K · 0.0% float · 1.0d Short vol52% DataJan 2020–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-6.4%
Year over year
Operating margin
-149.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+153.5%
Year over year · more shares
Price change (1Y)
-20.8%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bullish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 19 · elevated Equity put/call 0.69
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −14%
below
Price vs 50-day avg +30%
above
RSI (14) 61
neutral
MACD trend Negative
52-week position 34%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +73%
trailing
6-month return −39%
trailing
YTD return −21%
this year
Relative strength −45%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+83% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of float · ▼ -6.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
11 holders — near 3-yr high, broad support
Squeeze score 39
low risk · 0–100
Fundamentals
Weak
Revenue growth −6%
Y/Y
Gross margin -0%
expanding
EPS growth −94%
Y/Y
Free cash flow $-12.8M
Buyback $25.0M
authorized
Quant / Vol
risk profile
Very High
Volatility 96%
annualized · 1-yr
Max drawdown −72%
past year
ATR 9.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−14% Bearish
Price vs 50-day avg
+30% Bullish
RSI (14)
61 Neutral
MACD trend
Negative Bearish
52-week position
34% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+83% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of float · ▼ -6.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
11 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $1 · 34% Range high $3
vs 200-day avg -14% vs 50-day avg +30%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Distribution — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AHG
Akso Health Group
this stock
$1.05B -20.7% -6.4% — 0.0%
MCK
Mckesson Corp
$118.03B +22.0% +3.1% 27.2 2.0%
COR
Cencora, Inc.
$63.16B -2.0% +9.3% 24.6 2.1%
CAH
Cardinal Health Inc
$58.04B +21.4% +14.2% — 3.2%
HSIC
Henry Schein Inc
$9.58B +12.4% +5.9% 25.1 7.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
11
% held
0.0%
Net QoQ
+54.7K sh
Top holder
RENAISSANCE TECHNOLOGIES…
Held Float
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Falling
Shares short
18.6K
Days to cover
1.0d
Change
-1.3K sh
View
Short Volume
Short vol %
52%
As of
Oct 23, 2026
Short Total
View
Fails to Deliver
FTD shares
744
Value
$513
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
63.9%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$13.8M
Net income (FY)
$-18.7M
EPS diluted
$0.01
View
Buybacks
Authorized
$25.0M
View
Filings
SEC Filings
Latest
20-F
Filed
Jul 23, 2026
This year
4
View

Performance

5D 20D 120D MTD YTD
AHG -3.7% +73.3% -39.3% +44.4% -20.7%
SPY -0.4% -1.5% +5.8% -0.4% +11.5%
vs SPY -3.3% +74.8% -45.1% +44.8% -32.2%

Capital returns

Buyback program · as of Dec 10, 2018
Authorized
$25.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1702318 CUSIP 98422P108 Visit website Investor relations